+

WO2002063009A8 - Proteines de mammiferes lp et reactifs associes - Google Patents

Proteines de mammiferes lp et reactifs associes

Info

Publication number
WO2002063009A8
WO2002063009A8 PCT/US2002/000525 US0200525W WO02063009A8 WO 2002063009 A8 WO2002063009 A8 WO 2002063009A8 US 0200525 W US0200525 W US 0200525W WO 02063009 A8 WO02063009 A8 WO 02063009A8
Authority
WO
WIPO (PCT)
Prior art keywords
mammalian proteins
related reagents
reagents
reagentsand
polypeptidesspecific
Prior art date
Application number
PCT/US2002/000525
Other languages
English (en)
Other versions
WO2002063009A2 (fr
WO2002063009A3 (fr
Inventor
Ramesh Rajani Bhatt
John Nels Calley
Josef Georg Heuer
Gerald Patrick Keleher
Joanne Sloan Lancaster
Qingqin Li
Deshun Lu
Bradley Jay Mills
Santosh Kumar Mishra
Douglas Raymond Perkins
Scott William Rowlinson
Rosamund Carol Smith
Eric Wen Su
He Wang
Yu Zhi
Original Assignee
Lilly Co Eli
Ramesh Rajani Bhatt
John Nels Calley
Josef Georg Heuer
Gerald Patrick Keleher
Joanne Sloan Lancaster
Qingqin Li
Deshun Lu
Bradley Jay Mills
Santosh Kumar Mishra
Douglas Raymond Perkins
Scott William Rowlinson
Rosamund Carol Smith
Eric Wen Su
He Wang
Yu Zhi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Ramesh Rajani Bhatt, John Nels Calley, Josef Georg Heuer, Gerald Patrick Keleher, Joanne Sloan Lancaster, Qingqin Li, Deshun Lu, Bradley Jay Mills, Santosh Kumar Mishra, Douglas Raymond Perkins, Scott William Rowlinson, Rosamund Carol Smith, Eric Wen Su, He Wang, Yu Zhi filed Critical Lilly Co Eli
Priority to EP02718810A priority Critical patent/EP1419250A2/fr
Priority to US10/470,390 priority patent/US20040126777A1/en
Priority to AU2002249928A priority patent/AU2002249928A1/en
Publication of WO2002063009A2 publication Critical patent/WO2002063009A2/fr
Publication of WO2002063009A3 publication Critical patent/WO2002063009A3/fr
Publication of WO2002063009A8 publication Critical patent/WO2002063009A8/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des molécules d'acides nucléiques isolées codant des polypeptides provenant d'un humain, ainsi que des réactifs associés (notamment des anticorps spécifiques aux polypeptides purifiés). L'invention concerne également des procédés d'utilisation desdits réactifs, ainsi que des kits diagnostiques.
PCT/US2002/000525 2001-02-02 2002-01-28 Proteines de mammiferes lp et reactifs associes WO2002063009A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP02718810A EP1419250A2 (fr) 2001-02-02 2002-01-28 Proteines de mammiferes lp et reactifs associes
US10/470,390 US20040126777A1 (en) 2002-01-28 2002-01-28 Lp mammalian proteins; related reagents
AU2002249928A AU2002249928A1 (en) 2001-02-02 2002-01-28 Lp mammalian proteins; related reagents

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US26635901P 2001-02-02 2001-02-02
US60/266,359 2001-02-02
US27056401P 2001-02-21 2001-02-21
US60/270,564 2001-02-21
US30505801P 2001-07-13 2001-07-13
US60/305,058 2001-07-13

Publications (3)

Publication Number Publication Date
WO2002063009A2 WO2002063009A2 (fr) 2002-08-15
WO2002063009A3 WO2002063009A3 (fr) 2004-03-18
WO2002063009A8 true WO2002063009A8 (fr) 2004-04-22

Family

ID=27401883

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/000525 WO2002063009A2 (fr) 2001-02-02 2002-01-28 Proteines de mammiferes lp et reactifs associes

Country Status (3)

Country Link
EP (1) EP1419250A2 (fr)
AU (1) AU2002249928A1 (fr)
WO (1) WO2002063009A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1434783A4 (fr) * 2001-03-16 2006-06-07 Lilly Co Eli Proteines de mammiferes lp et reactifs associes
JP4851327B2 (ja) * 2003-09-02 2012-01-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 上皮−間葉移行に関与するサイトカイン
WO2014097978A1 (fr) * 2012-12-19 2014-06-26 国立大学法人滋賀医科大学 Composition pharmaceutique destinée au traitement et/ou à la prévention de maladies liées à une accumulation anormale de protéine bêta-amyloïde

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000353A1 (fr) * 1991-06-20 1993-01-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequences caracteristiques de produit de transcription de genes humains

Also Published As

Publication number Publication date
AU2002249928A1 (en) 2002-08-19
EP1419250A2 (fr) 2004-05-19
WO2002063009A2 (fr) 2002-08-15
WO2002063009A3 (fr) 2004-03-18

Similar Documents

Publication Publication Date Title
WO2002020569A3 (fr) Genes mammaliens, reactifs et methodes associes
EP2100959A3 (fr) Cytokine de mammifères: interleukine-B30 et réactifs apparentés
WO2004033631A8 (fr) Sequences d'acides nucleiques et polypeptidiques de lawsonia intracellularis et methodes d'utilisation
EP1897949A3 (fr) Utilisations thérapeutiques d'interleukine-B50 humaine
WO2000042188A3 (fr) Cytokines de mammiferes liees a l'interleukin-17, polynucleotides les codant et leurs utilisations
WO1998001557A3 (fr) Reactifs apparentes a des chemokines mammaliennes
EP1942114A3 (fr) "Cytokines de mammifères ; réactifs et procédés associés"
WO1998011226A3 (fr) Chemokines de mammiferes et reactifs apparentes
WO2003020005A3 (fr) Proteines de mammiferes lp et reactifs associes
WO1998023750A3 (fr) Chemokines de mammiferes
WO1999003993A3 (fr) Suppresseurs de signalement de cytokine et reactifs correspondants
WO1998039421A3 (fr) Proteinase mammaliennes, oxydoreductase, proteines de liaison avec gtp et reactifs correspondants
WO1998032858A3 (fr) Chemokines de mammiferes, recepteurs, reactifs, et modes d'utilisation
WO2002074906A3 (fr) Proteines de mammiferes lp et reactifs associes
WO2002068596A3 (fr) Cytokines de mammifere, reactifs associes
WO2001064713A3 (fr) Variants du recepteur d'interleukine-10 (il-10) des mammiferes
WO2002063009A3 (fr) Proteines de mammiferes lp et reactifs associes
WO2002026929A3 (fr) Proteine moteur kini-3 et methodes d'utilisation associees
WO1999047673A3 (fr) Genes de proteines membranaires mammiferes isoles, et reactifs associes
WO2003012120A3 (fr) Proteine secretee de mammifere lp354
WO1998031810A3 (fr) Chemokines de mammiferes, recepteurs, reactifs, utilisations
EP0997476A3 (fr) Anticorps contre un antigène de cellules Langerhans mammifères et leurs utilisations
WO2002033084A3 (fr) Identification de la glycoproteine du groupe sanguin dombrock utilisee en tant qu'element polymorphe de la famile du gene de l'adp/ribosyltransferase
WO2003022992A3 (fr) Genes mammiferes et reactifs associes
WO2001096593A3 (fr) Nouvelles proteines motrices et procedes d'utilisation de ces proteines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10470390

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002718810

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 33/2002 DUE TO A TECHNICAL PROBLEMAT THE TIME OF INTERNATIONAL PUBLICATION, SOME INFORMATION WAS MISSING UNDER (81). THE MISSING INFORMATION NOW APPEARS IN THE CORRECTED VERSION

WWP Wipo information: published in national office

Ref document number: 2002718810

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002718810

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载